For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
Jump to a slide with the slide dots.
Discover five key frontiers reshaping oncology, from biomarker breakthroughs and ctDNA diagnostics to ADC innovations, early intervention, and true..
Read moreDiscover expert-backed strategies to ensure a successful life sciences product launch - align teams, avoid pitfalls, and accelerate market impact.
Read moreDiscover how AI is revolutionizing pharma commercialization in 2025. Learn how Inizio helps life sciences teams scale AI for real-world performance.
Read more